A Study to Evaluate a Postbiotic for Weight Loss and Metabolic Health

This study is looking at how a dietary supplement called resM™ Postbiotic, which contains a specific postbiotic (L. plantarum RSB11® HI), along with Vitamin D, Vitamin B12, Chromium, White mulberry leaf extract, and Fenugreek, might help with weight loss and metabolic health. You could be eligible to join if you are between 18 and 65 years old, have a Body Mass Index (BMI) between 25.0 and 40.0 (meaning you are overweight or have obesity), and are generally in good health. The researchers want to see if taking resM™ Postbiotic affects your weight, BMI, and food cravings after 8 weeks. This study is currently unclear about its recruitment status and plans to enroll 80 participants.

Study design
This study is interventional, meaning participants will receive either the resM™ Postbiotic supplement or a placebo (an inactive substance). It plans to enroll 80 participants.
What's involved
You would need to maintain your current diet and physical activity throughout the study period. The primary outcomes are measured at 8 weeks.
Compensation
Not stated in the trial record.
Follow-up
The primary outcomes are measured at 8 weeks, which indicates the duration of the main observation period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06911073

A Study to Evaluate a Postbiotic in Supporting Weight Loss and Metabolic Health

Completed
NAAges 18–65Interventional
ResBiotic Nutrition, Inc.
~80 participants
Updated 2026-08-14 on ClinicalTrials.gov
What's tested:PostbioticPlacebo

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To determine the effect of resM™ on weight
Measured over 8 weeks
+5 more outcomes measured
Obesity and Overweight
1 sites across 1 states
Alabama1
  • Ahmed Abdelgawad, MD · PRINCIPAL_INVESTIGATOR · Able Biolabs, LLC

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • To determine the effect of resM™ on weight8 weeks

    Change from baseline in weight (lb)

  • To determine the effect of resM™ on BMI8 weeks

    Change from baseline in BMI. Weight and height will be combined to report BMI in kg/m\^2)

  • To determine the effect of resM™ on food cravings8 weeks

    Change in reported food cravings from baseline based on Food Craving Questionnaire Trait-reduced (FCQ-T-r) scores. The total score reflects the severity of food cravings where 90 indicates the most severe and 15 indicates the least severe.

  • To determine the effect of resM™ on blood metabolic markers8 weeks

    Change from baseline in serum fasting glucose

  • To determine the effect of resM™ on blood metabolic markers8 weeks

    Change from baseline in serum insulin levels

  • To determine the effect of resM™ on blood metabolic markers8 weeks

    Change from baseline in whole blood HbA1c (glycated hemoglobin)